Should Drug Manufacturers - Specialty & Generic Stock PainReform Ltd (PRFX) Be in Your Portfolio Wednesday?

A rating of 77 puts PainReform Ltd (PRFX) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. PainReform Ltd's score of 77 means it scores higher than 77% of stocks in the industry. PainReform Ltd also received an overall rating of 55, putting it above 55% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 99 out of the 148 industries.

PRFX has an Overall Score of 55. Find out what this means to you and get the rest of the rankings on PRFX!

See Full PRFX Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With PainReform Ltd Stock Today?

PainReform Ltd (PRFX) stock is higher by 0.32% while the S&P 500 is down -0.06% as of 10:11 AM on Wednesday, Oct 4. PRFX is up $0.01 from the previous closing price of $3.10 on volume of 7,143 shares. Over the past year the S&P 500 is higher by 11.50% while PRFX is down -51.33%. PRFX lost -$9.05 per share the over the last 12 months. Click Here to get the full Stock Report for PainReform Ltd stock.